Prescrire

{{Infobox journal | title = Prescrire | image = | publisher = Association mieux prescrire | editor = | discipline = Medicine, pharmacology | language = French | abbreviation = Prescrire | country = France | frequency = Monthly | history = 1981–present | open access = | impact = | impact-year = | website = http://www.prescrire.org | JSTOR = | OCLC = 46999191 | LCCN = | CODEN = | ISSN = 0247-7750 | eISSN = }} '''''Prescrire''''' also known as '''''La Revue Prescrire''''' is a monthly medical journal in French which addresses developments in diseases, medications, and in medical techniques and technologies. ''Prescrire'' contains no advertising,<ref name="PRERUE89">{{cite web|url=http://www.rue89.com/2010/12/07/prescrire-la-revue-medicale-qui-dit-non-merci-aux-labos-179472|title=Prescrire, la revue médicale qui dit " non, merci " aux labos |author=Nolwenn Le Blevennec|work=Rue89|date=7 December 2010|accessdate=23 January 2011}}</ref> and is internally financed by subscriptions and the sale of various personnel training. In contrast to many traditional medical journals, which review and publish articles submitted by external researchers, Prescrire mainly publishes reviews prepared by its own staff.

It is run by the Association Mieux Prescrire which is a not for profit.<ref name=CFP1999>{{cite journal|last1=Reid|first1=T|title=Welcome to Prescrire! Evidence-based reviews of drugs.|journal=Canadian Family Physician|date=May 1999|volume=45|pages=1133–4, 1140–1|pmid=10349047|pmc=2328578}}</ref> It is independent of the pharmaceutical industry.<ref name=CFP1999/> Superlatively, it forbids, rather than merely requiring disclosure of, conflicts of interest, through its "Non Merci..." charter. It is a member of the International Society of Drug Bulletins.<ref>{{cite web|last1=Chirac|first1=P|title=ISDB: The International Society of Drug Bulletins|url=http://apps.who.int/medicinedocs/es/d/Js16518e/4.9.html|archive-url=https://web.archive.org/web/20140719194311/http://apps.who.int/medicinedocs/es/d/Js16518e/4.9.html|url-status=dead|archive-date=July 19, 2014|website=WHO|accessdate=30 June 2014}}</ref>

As of 2013 it had 24,700 paying subscribers.<ref>{{cite web|title=Financing|url=https://prescrire.org/Fr/38CC80DD8C7325BF9E177E0211F8AA7E/Download.aspx|accessdate=19 August 2024}}</ref> It was among the first to warn against the dangers of Mediator.<ref name="PRERUE89"/><ref>{{cite web|url=http://www.arretsurimages.net/contenu.php?id=3680|title=Il faudrait un ''Prescrire'' pour le grand public !|work=Arrêt sur images|date=21 January 2011|accessdate=23 January 2011}}</ref> ''Prescrire'' also publishes an international edition in English, titled '''''Prescrire International'''''.

==Publication== The articles are based on a search of the literature and critical appraisal of the evidence.<ref>{{cite web|title=Clinical Pearls from Prescrire|url=http://www.ti.ubc.ca/letter60|website=Therapeutics Initiative|accessdate=29 June 2014}}</ref> Each article is peer-reviewed by 20-40 reviewers.<ref name=CFP1999/>

== History == The journal was established in 1981 by a group of pharmacists and physicians with a subsidy from the French Ministry of Labour, Employment, and Health.<ref name=PRERUE89/>

== References == {{Reflist}}

==External links== * {{Official website|http://www.prescrire.org}}

Category:Academic journals established in 1981 Category:Monthly journals Category:French-language journals Category:Pharmacology journals